UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study
Charlie Song-Smith, Edward Jacobs, James Rucker, Matthew Saint, James Cooke, Marco Schlosser
BMJ Open March 1, 2024 DOI: 10.1136/bmjopen-2023-083595 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 132 |
| Population | UK medical students |
| Keywords | Student perspectives Cross-sectional studies Medical education Psychedelic medicine Psychiatry training Cross-sectional research |
| Citations | 9 |
| Key findings | UK medical students show strong support for changing the legal status of psychedelics to facilitate further research, but most feel poorly educated on the topic. |
Abstract
Objective: To capture UK medical students’ self-reported knowledge and harm assessment of psychedelics and to explore the factors associated with support for changing the legal status of psychedelics to facilitate further clinical research.
Design: Cross-sectional, anonymous online survey of UK medical students using a non-random sampling method.
Setting: UK medical schools recognised by the General Medical Council.
Participants: 132 medical students who had spent an average of 3.8 years (SD=1.4; range: 1–6) in medical school.
Results: Most students (83%) reported that they were aware of psychedelic research and only four participants (3%) said that they were not interested in learning more about this type of research. Although medical students’ harm assessment of psychedelics closely aligned with that of experts, only 17% of students felt well-educated on psychedelic research. Teachings on psychedelics were only rarely encountered in their curriculum (psilocybin: 14.1 (SD=19.9), scale: 0 (never) to 100 (very often)). Time spent at medical schools was not associated with more knowledge about psychedelics (r=0.12, p=0.129). On average, this sample of medical students showed strong support for changing the legal status of psychedelics to facilitate further research into their potential clinical applications (psilocybin: 80.2 (SD=24.8), scale: 0 (strongly oppose) to 100 (strongly support)). Regression modelling indicated that greater knowledge of psychedelics (p<0.001), lower estimated harm scores (p<0.001), more time spent in medical school (p=0.024) and lower perceived effectiveness of non-pharmacological mental health treatments (p=0.044) were associated with greater support for legal status change.
Conclusions: Our findings reveal a significant interest among UK medical students to learn more about psychedelic research and a strong support for further psychedelic research. Future studies are needed to examine how medical education could be refined to adequately prepare medical students for a changing healthcare landscape in which psychedelic-assisted therapy could soon be implemented in clinical practice.
Citations in the library
Cited by 6
- From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics? Journal of Psychoactive Drugs September 11, 2025
- Psychiatric Residents' Perspectives on Psychedelics and Psychedelic Assisted Therapy. Journal of Psychoactive Drugs July 2, 2025
- Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA SAIMSARA Journal June 15, 2026
- Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics". Global Advances in Integrative Medicine and Health 2026
- Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distress Research Square September 18, 2024
and 1 more in the library
Cites 32
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Global Street Food: la cocina de la calle Diseño interior 2009
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics May 1, 2019
and 27 more in the library